Results 21 to 30 of about 94,073 (238)

Genomics of Myeloproliferative Neoplasms [PDF]

open access: yesJournal of Clinical Oncology, 2017
Myeloproliferative neoplasms (MPNs) are a group of related clonal hematologic disorders characterized by excess accumulation of one or more myeloid cell lineages and a tendency to transform to acute myeloid leukemia. Deregulated JAK2 signaling has emerged as the central phenotypic driver of BCR -ABL1–negative MPNs and a unifying therapeutic target. In
Zoi, Katerina, Cross, Nicholas
openaire   +2 more sources

Epigenetics in myeloproliferative neoplasms

open access: yesFrontiers in Oncology, 2023
The myeloproliferative neoplasms (MPNs) are a group of acquired clonal disorders where mutations drive proliferative disease resulting in increased blood counts and in some cases end-stage myelofibrosis. Epigenetic changes are the reversible modifications to DNA- and RNA-associated proteins that impact gene activity without changing the DNA sequence ...
Greenfield, Graeme   +1 more
openaire   +4 more sources

Genetics of Myeloproliferative Neoplasms [PDF]

open access: yesThe Cancer Journal, 2014
In the last decade, genomic studies have identified multiple recurrent somatic mutations in myeloproliferative neoplasms (MPNs). Beginning with the discovery of the JAK2 V617F mutation, multiple additional mutations have been found that constitutively activate cell-signaling pathways, including MPL, CBL, and LNK.
Aaron D, Viny, Ross L, Levine
openaire   +2 more sources

Unbalanced rearrangement, der(9;18)(p10;q10) in a patient with myeloproliferative neoplasm. Case 0001M. [PDF]

open access: yes, 2011
Case report of a translocation : Unbalanced rearrangement, der(9;18)(p10;q10) in a patient with myeloproliferative neoplasm. Case 0001M.
Reddy, KS
core   +1 more source

A CASE OF HEADACHE TURNING INTO MYELOPROLIFERATIVE NEOPLASM-A CASE REPORT

open access: yes, 2023
<p>Headache is an important clinical symptom commonly encountered by practising physicians. Thorough history and physical examination is a must for arriving at differentials of headache.
Sreeraj H.
core   +1 more source

Update in the myeloproliferative neoplasms [PDF]

open access: yesClinical Medicine, 2014
The differential diagnosis of haematological abnormalities, such as leucocytosis, erythocytosis, thrombocytosis or indeed anaemia, is wide and disarming. Here we report on significant updates in the differential diagnosis of erythrocyosis and thrombocytosis presenting a simplified schema for the clinician.
Harrison, Claire N, McMullin, Mary F
openaire   +3 more sources

Corticosteroid-resistant Sweet’s syndrome as the first manifestation of myelodysplastic/ myeloproliferative neoplasm-unclassifiable: a case report

open access: yes, 2022
. A middle-aged man was diagnosed with myelodysplastic/myeloproliferative neoplasm-unclassifiable (MDS/MPN-U), with severe and extensive corticosteroid-resistant Sweet’s syndrome (SS) as the first manifestation, with evidence of clinical manifestations ...
Chuanli Zhao   +9 more
core   +1 more source

Genetics of Myeloproliferative Neoplasms

open access: yesHematology/Oncology Clinics of North America, 2021
Myeloproliferative neoplasms are hematopoietic stem cell disorders based on somatic mutations in JAK2, calreticulin, or MPL activating JAK-STAT signaling. Modern sequencing efforts have revealed the genomic landscape of myeloproliferative neoplasms with additional genetic alterations mainly in epigenetic modifiers and splicing factors.
Jakub, Szybinski, Sara C, Meyer
openaire   +2 more sources

Aetiology of Myeloproliferative Neoplasms [PDF]

open access: yesCancers, 2020
Myeloproliferative neoplasms (MPNs) have estimated annual incidence rates for polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis of 0.84, 1.03, and 0.47 per 100,000. Prevalence is much higher, particularly for PV and ET, as mortality rates are relatively low.
Mary Frances McMullin   +1 more
openaire   +4 more sources

Extracranial carotid artery aneurysm with myeloproliferative neoplastic cell invasion

open access: yesJournal of Vascular Surgery Cases and Innovative Techniques, 2020
The major causes of rare extracranial carotid artery aneurysms are arteriosclerosis, trauma, and radiation therapy. Here, we describe a patient with an extracranial carotid artery aneurysm caused by a myeloproliferative neoplasm.
Shotaro Ogawa, MD   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy